Health, demographic change and wellbeing

November 12th, 2017 

The Work Programme 2018-2020 for the Societal Challenge 1 SC1, Health, Demographic Change & Wellbeing of Horizon 2020 

The EU’s Research and Innovation funding programme, was launched on October 27th, 2017 by the European Commission. Horizon 2020 is the largest multinational programme dedicated to research & innovation and it is « open to the world ». This means that researchers, universities, research organisations, companies and non-governmental organisations from across the globe can apply to participate in the activities of the Work Programme carried out mainly through calls for proposals.

Here enclosed the Work Programme 2018-2020 for the Societal Challenge 1, Health, Demographic Change & Wellbeing.

http://ec.europa.eu/research/participants/data/ref/h2020/wp/2018-2020/main/h2020-wp1820-health_en.pdf  

 

Call 1. Better Health and Care, Economic Growth & Sustainable Health Systems 

1.1 Personalised Medicine 

SC1-BHC-03-2018: Exploiting research results and potential of the human microbiome for personalised prediction and prevention of disease    RIA  13 & 14 M€

SC1-BHC-04-2018: Rare Disease Joint Programme Co-Fund    COFUND (European Joint Programme)     50 M€

SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing for developing personalised medicine approaches   RIA    6 M€ over 4 years

SC1-BHC-01-2019: Understanding causative mechanisms in co-morbidities   RIA   4 & 6 M€

SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies   RIA   4 & 6 M€

SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine  CSA  1.5 & 2 M€

SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine – a European standardization framework  CSA    1.5 & 2 M€

SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)  ERA-NET Cofund   5 & 6 M€

1.2 Innovative health and care industry 

SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future  RIA  6-8 M€

SC1-HCO-05-2018: Strengthen Regulatory Sciences and support for successful regulatory Scientific Advice CSA  1-2 M€

SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications  RIA  6-8 M€

SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis RIA  12-15 M€

1.3 Infectious diseases and improving global health 

SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)     RIA   5 -10 M€

SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) 1  RIA  1 – 3 M€

SC1-BHC-21-2018: Research on HIV and/or tuberculosis in patients with mono-, co-infections or comorbidities in the contest of fostering the collaboration with (alt. widening the participants to) Russia and other countries in the Central- and Eastern European region  RIA  2 – 4 M€

SC1-HCO-06-2018: Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), Establishment of an International Network of Research Centres on Global Governance for Infectious Disease Preparedness  CSA in progress M€

SC1-HCO-09-2018: Building international efforts on cohorts  CSA  1.5 – 2 M€

SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives  CSA  1 – 2 M€

SC1-HCO-11-2018: Strategic collaboration in healthcare research and innovation between EU & China CSA  1.5 – 2 M€

SC1-BHC-13-2019: Preparedness research for (Re-) Emerging Infectious Diseases  RIA   12-15 M€

SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention &/or treatment of infectious diseases    RIA 6-10 M€

SC1-BHC-18-2019: EU-CELAC collaboration for research on non-communicable diseases  RIA 1-3 M€

SC1-BHC-19-2019: Implementation research for maternal and child health  RIA 2-4 M€

SC1-HCO-08-2019: Creation of a European wide sustainable clinical research networks for infectious diseases  CSA 2-3 M€

1.4. Innovative health and care systems – Integration of care  

SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation & end-of-life care RIA   3-4M€

SC1-BHC-26-2018: HTA research to support evidence-based healthcare  RIA  8-10M€

SC1-HCO-12-2018: Innovation in health care – towards using pre-commercial procurement & public procurement of innovative solutions in health care systems  CSA  2-3M€

SC1-BHC-22-2019: Mental health in the workplace    RIA   2-4M€

SC1-BHC-25-2019: Demonstration pilots for implementation of Personalised Medicine in health care RIA  15-20M€

1.5 Decoding the role of the environment for health and well-being 

SC1-BHC-27-2018: Endocrine disrupters – research for better regulation and improved understanding of health effects   RIA   4-6M€

SC1-HCO-13-2018: Setting the Priorities for the European Environment and Health Agenda    CSA   1.5-2M€

SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment and climate change on health  RIA   8-12M€

Call 2. – Digital transformation in Health and Care  

Call 3. – Trusted digital solutions and Cybersecurity in Health and Care  

 

 

TOPIC : Horizon Prize – Birth Day

Identifiant du thème : H2020-Birth Day Prize-2016
Date de Publication :

 

 

 

Montant alloué au prix:

28 Avril 2016

http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/h2020-birthdayprize-2016.html

 

1 million EUR

 

Types d’action : IPr Inducement Prize
Modèle d’échéance : 
Date d’ouverture :
Echéance unique
28 Avril 2016
Date d’échéance : 06 Septembre 2017 17:00:00
Fuseau horaire : (Heure de Bruxelles)

 

Le prix Horizon sur la réduction de la morbidité et de la mortalité maternelles et néonatales – le Prix Birth Day – sera attribué aux concurrents qui démontrent une nouvelle solution pour améliorer les résultats des accouchements basées sur les installations, qui peuvent être de nature clinique, technologique ou de gestion, ou une combinaison de ceux-ci. Toute solution doit tenir compte des facteurs sociaux pertinents et avoir le potentiel de progresser rapidement.

Plus de détails dans ce document.

Mots-clés: morbidité, mortalité maternelle, mortalité néonatale, innovation d’installation clinique, innovation technologique, innovation de gestion.

 

TOPIC : Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks

Identifiant du thème : IMI2-2015-08-01
Date de Publication :

 

 

Budget (EUR) – Année : 2015

18 Décembre 2015

http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2015-08-01.html

70,000,000 EUR

 

Types d’action : IMI2-RIA Research and Innovation action
Modèle d’échéance : 
Date d’ouverture :
Echéance multiple
18 Décembre 2015
Dates d’échéance : 16 March 2016 17:00:00
15 September 2016 17:00:00
16 March 2017 17:00:00
14 September 2017 17:00:00
15 March 2018 17:00:00
Fuseau horaire : (heure de Bruxelles)

Description

La récente épidémie de maladie du virus Ebola (EVD) en Afrique de l’Ouest souligne la vulnérabilité des populations du monde entier aux agents pathogènes tels que les virus filoviraux. À l’heure actuelle, il n’existe pas de vaccins ou de médicaments antiviraux approuvés pour la prévention ou le traitement des infections filovirales chez l’homme.

 

Mots clés: Maladie du virus Ebola (EVD), filovirus, virus, vaccin, stratégies de fabrication, stabilité des vaccins, plateformes, consortium public-privé.